The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation
- 13 May 2021
- journal article
- research article
- Published by Springer Nature in BioSocieties
- Vol. 17 (3) , 549-576
Abstract
As digital health technologies (DHT) have been embraced as a ‘panacea’ for health care systems, they have evolved from a buzzword into a high pKeywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (11C8520N, 3H140131)
- H2020 Marie Skłodowska-Curie Actions (753531)
This publication has 48 references indexed in Scilit:
- Comparing technological hype cycles: Towards a theoryTechnological Forecasting and Social Change, 2013
- Response to John Ferejohn's review of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDAPerspectives on Politics, 2012
- Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulationSociology of Health & Illness, 2011
- PRAGMATICS AND POLITICSJournal of Cultural Economy, 2010
- PERFORMATIVITY, ECONOMICS AND POLITICSJournal of Cultural Economy, 2010
- Deficits, Expectations and Paradigms in British and American Drug Safety AssessmentsScience, Technology, & Human Values, 2007
- Creating a New Object of GovernmentSocial Studies of Science, 2006
- The sociology of expectations in science and technologyTechnology Analysis & Strategic Management, 2006
- Science, Politics, and the Pharmaceutical Industry: Controversy and Bias in Drug RegulationTechnology and Culture, 1998
- Regulatory science—Towards a sociological frameworkFutures, 1997